Product
Supplier
Encyclopedia
Inquiry
Sichuan Duorui - Retatrutide buy - large image1
Sichuan Duorui - Retatrutide buy - image1

Sichuan Duorui - Retatrutide

COA 6083 Inquiries

Unit Price: Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Chengdu

Packaging:

depends on customers' needs

Price valid (until):

2025-12-27

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

Semaglutide,Tirzepatide,Retatrutide,Lanreotide Acetate,Pegcetacoplan

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Retatrutide API, Retatrutide Peptide,GLP-1

    Indications: Type 2 diabetes & Obesity

    Contact Person:Delia Zhong

    Wechat/Tel:  +86 184 8235 1102

    E-mail:deliazhong@duoruipharm.com

    Website:https://www.duoruibiopharm.com


    Items Specifications
    Product Name Retatrutide 
    CAS  2381089-83-2
    Purity ≥99% (HPLC)

    Certificates

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    LY3437943;Retatrutide;GIPR/GLP-1R;Retatrutide/LY3437943/GIPR/GLP-1R;Retaglutide;Retatrutide acetate;LY3437943Retatrutide;Retalutide

    CAS No.:

    2381089-83-2

    Molecular Weight:

    0

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Categories:

    Drug Metabolism

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Semaglutide,Tirzepatide,Retatrutide,Lanreotide Acetate,Pegcetacoplan

    Location:

    No. 76 Jinle Road, Chengdu-Aba Industrial Concentration Development Zone, Jintang County, Chengdu City, Sichuan Province, China

    Payment Terms:

    TT against copy of documents,L/C,100% TT in advance

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    101-200

    Year of Establishment:

    2018

    Established in 2018 and located in Jintang County, Chengdu, Sichuan Province, focuses on the R&D and production of peptide APIs. The company covers an area of ​​200,000 square meters, has a GMP production workshop, possesses advanced peptide drug preparation technology, and has large-scale peptide production capabilities, providing high-quality, low-cost, and fast-response product services.

    Main products: Lanreotide Acetate, Semaglutide, Tirzepatide, Retatrutide, Teriparatide, etc.

    Capacity:
    Peptide for human use: 500 kg
    Peptide for Veterinary use: 200 kg

    Oct., 2024: "Albuvirtide" API passed the NMPA GMP compliance inspection.
    Aug. 2023: "Teriparatide" Injection"assembly line passed US FDA site inspection with no 483 observation.

  • Inquiry History
    6083 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    Tirzepatide 99.9% Liquid 2381089-83-2 TeruiOP

    1 MT Sep 6, 2023
    United States

    Retatrutide/LY3437943/GIPR/GLP-1R 98% Powder 2381089-83-2 Senwayer

    1 G Sep 3, 2023
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2

    10  Oct 21, 2023
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.